Fildena CT 50 follows a typical pharmacokinetic profile, involving absorption, distribution, metabolism, and excretion (ADME). However, in patients with renal impairment, particularly those with reduced glomerular filtration rate (GFR), the clearance of Fildena CT 50 and its metabolites may be impaired. This can potentially lead to drug accumulation, prolongation of action, and increased risk of adverse effects.
https://www.flatmeds.com/product/fildena-ct-50-mg/
お気に入り
コメント
シェア
